ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

EPRX Eupraxia Pharmaceuticals Inc

3,69
0,00 (0,00%)
Zuletzt aktualisiert: 15:43:42
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Eupraxia Pharmaceuticals Inc EPRX Toronto Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 3,69 15:43:42
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,69
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202413:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08.4.202413:00PRNUSEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05.4.202413:00PRNCAEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03.4.202423:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01.4.202423:01PRNUSEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15.3.202413:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12.3.202414:41PRNCAL'Organisme canadien de réglementation des investissements..
12.3.202414:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12.3.202414:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11.3.202421:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11.3.202421:06PRNCASuspension de la négociation par l'Organisme canadien de..
11.3.202421:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05.2.202423:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01.2.202413:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30.1.202413:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
09.1.202400:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12.12.202313:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11.12.202313:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
14.11.202323:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01.11.202312:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11.10.202313:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
11.9.202321:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07.9.202323:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
06.9.202323:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
19.8.202301:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
11.8.202323:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04.8.202313:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26.6.202313:00PRNCAEupraxia Pharmaceuticals Reports Positive Topline Data in..
16.6.202300:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
13.6.202317:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13.6.202313:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13.6.202313:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08.6.202313:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
25.5.202313:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
18.5.202313:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
11.5.202313:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..
20.4.202313:00PRNCAEupraxia Pharmaceuticals To Present at Bloom Burton & Co...

Kürzlich von Ihnen besucht

Delayed Upgrade Clock